SLC14A1 and colorectal carcinoma: Another investigation in CRC reported that SLC14A1 as a DEG may act as a key regulator in CRC metachronous liver metastasis, with its expression level shows a significant association with both recurrence-free survival and overall survival in individuals diagnosed with colorectal cancer [49].